Functional identification of lipoprotein Lp(a) in plasma from patients with cardiovascular disease

被引：0
|
作者：
delaPena, A
Loyau, S
Izaguirre, R
AnglesCano, E
机构：
[1] Univ Nacl Autonoma Mexico, FAC MED, DEPT PHARMACOL, MEXICO CITY, DF, MEXICO
[2] HOP BICETRE, INSERM U143, PARIS, FRANCE
来源：
THROMBOSIS AND HAEMOSTASIS | 1997年
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：P1330 / P1330
页数：1
相关论文
共 50 条
  • [21] Plasma concentration of lipoprotein(a) and the risk of future cardiovascular disease in women
    Danik, JS
    Rifai, N
    Buring, JE
    Ridker, PM
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 314A - 314A
  • [22] IMMUNOCHEMICAL QUANTIFICATION OF HUMAN PLASMA LP(A) LIPOPROTEIN
    ALBERS, JJ
    HAZZARD, WR
    LIPIDS, 1974, 9 (01) : 15 - 26
  • [23] RADIOIMMUNOASSAY OF HUMAN-PLASMA LP(A) LIPOPROTEIN
    ALBERS, JJ
    ADOLPHSON, JL
    HAZZARD, WR
    JOURNAL OF LIPID RESEARCH, 1977, 18 (03) : 331 - 338
  • [24] LP(A) LIPOPROTEIN AND PRE-BETA-1-LIPOPROTEIN IN PATIENTS WITH CORONARY HEART-DISEASE
    BERG, K
    DAHLEN, G
    FRICK, MH
    CLINICAL GENETICS, 1974, 6 (03) : 230 - 235
  • [25] LP(A) GLYCOPROTEIN PHENOTYPES - INHERITANCE AND RELATION TO LP(A)-LIPOPROTEIN CONCENTRATIONS IN PLASMA
    UTERMANN, G
    MENZEL, HJ
    KRAFT, HG
    DUBA, HC
    KEMMLER, HG
    SEITZ, C
    JOURNAL OF CLINICAL INVESTIGATION, 1987, 80 (02) : 458 - 465
  • [26] LIPOPROTEIN (LP)(A) LEVELS IN PREMATURE CORONARY-ARTERY DISEASE PATIENTS
    SCHAEFER, EJ
    GENEST, JJ
    JENNER, JL
    MCNAMARA, JR
    SILBERMAN, S
    USHER, DC
    WILSON, PWF
    ORDOVAS, JM
    CLINICAL CHEMISTRY, 1990, 36 (06) : 957 - 957
  • [27] L-carnitine reduces plasma lipoprotein(a) levels in patients with hyper Lp(a)
    Sirtori, CR
    Calabresi, L
    Ferrara, S
    Pazzucconi, F
    Bondioli, A
    Baldassarre, D
    Birreci, A
    Koverech, A
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2000, 10 (05) : 247 - 251
  • [28] Lipoprotein Lp(a) in patients with rheumatoid arthritis. Correlation with disease activity
    Athanassiou, P.
    Kostoglou-Athanassiou, I.
    Kyriakos, G.
    Galanaki, C.
    Kalogirou, T.
    Kaldrymidis, P.
    Antoniadis, C.
    Kordalis, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 161 - 161
  • [29] Influence of lipoprotein apheresis on circulating plasma levels of miRNAs in patients with high Lp(a)
    Dlouha, Dana
    Prochazkova, Iveta
    Eretova, Zuzana
    Hubacek, Jaroslav A.
    Parikova, Alena
    Pitha, Jan
    ATHEROSCLEROSIS SUPPLEMENTS, 2019, 40 : 12 - 16
  • [30] Lipoprotein(a) and cardiovascular disease
    Nordestgaard, Barge G.
    Langsted, Anne
    LANCET, 2024, 404 (10459) : 1255 - 1264
12345